Advertisement

Research Article Free access | 10.1172/JCI103011

Effects of Infusion of Hyperoncotic Dextran in Children with the Nephrotic Syndrome

John James, Gustavo Gordillo, and Jack Metcoff

aDepartment of Pediatrics, Harvard Medical School and Children's Medical Center, Boston, Mass.

2

Milton Fellow, 1951-53, Department of Pediatrics, Harvard Medical School.

3

Fellow, Eli Lilly Company.

1

Aided in part by Grant No. H748 (C2) from the National Heart Institute of the National Institutes of Health, United States Public Health Service.

Find articles by James, J. in: PubMed | Google Scholar

aDepartment of Pediatrics, Harvard Medical School and Children's Medical Center, Boston, Mass.

2

Milton Fellow, 1951-53, Department of Pediatrics, Harvard Medical School.

3

Fellow, Eli Lilly Company.

1

Aided in part by Grant No. H748 (C2) from the National Heart Institute of the National Institutes of Health, United States Public Health Service.

Find articles by Gordillo, G. in: PubMed | Google Scholar

aDepartment of Pediatrics, Harvard Medical School and Children's Medical Center, Boston, Mass.

2

Milton Fellow, 1951-53, Department of Pediatrics, Harvard Medical School.

3

Fellow, Eli Lilly Company.

1

Aided in part by Grant No. H748 (C2) from the National Heart Institute of the National Institutes of Health, United States Public Health Service.

Find articles by Metcoff, J. in: PubMed | Google Scholar

Published October 1, 1954 - More info

Published in Volume 33, Issue 10 on October 1, 1954
J Clin Invest. 1954;33(10):1346–1357. https://doi.org/10.1172/JCI103011.
© 1954 The American Society for Clinical Investigation
Published October 1, 1954 - Version history
View PDF
Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (October 1, 1954): No description
Advertisement
Advertisement